The chart below shows how CME performed 10 days before and after its earnings report, based on data from the past quarters. Typically, CME sees a -1.64% change in stock price 10 days leading up to the earnings, and a +0.73% change 10 days following the report. On the earnings day itself, the stock moves by +0.39%. This data can give you a slight idea of what to expect for the next quarter's release.
Positive
Record Quarterly Volume: The third quarter averaged daily volume of 28.3 million contracts, the highest quarterly ADV in CME Group's history, increasing 27% compared to the same period last year.
Financial Products Volume Growth: Our financial products volume grew by 28% and our commodity sector volumes grew by 20%.
Consistent Growth Across Assets: We achieved year-over-year growth in both volume and open interest across every asset class for the second consecutive quarter.
SOFR Trading Activity: Our SOFR complex traded over 5.9 million contracts per day in the quarter and 6.9 million per day in September, while seeing the customer network broaden with large open interest holders reaching a new record high in September.
Record Quarterly Performance: CME Group set all-time records for quarterly revenue, net income, and earnings per share in the second quarter this year and immediately surpassed each of those records this quarter, starting with the highest ever quarterly revenue at nearly $1.6 billion, up 18% from the third quarter in 2023.
Negative
Customer Growth Decline: CME Group reported a decline in customer growth, with a decrease of 15% in new accounts compared to the previous quarter.
Operating Income Decline: The company experienced a significant drop in segment operating income, which fell by 20% year-over-year, indicating challenges in profitability.
Operating Expenses Increase: CME Group's operating expenses increased by 10% compared to the same quarter last year, impacting overall financial performance.
Trading Volume Decline: The average daily trading volume decreased by 5% compared to the previous quarter, reflecting reduced market activity.
Earnings Decline Analysis: CME Group's adjusted earnings per share fell to $2.68, down 10% from the same period last year, highlighting a decline in profitability.
CME Group Inc. (CME) Q3 2024 Earnings Call Transcript
CME.O
0.9%